View More View Less
  • 1 National Center for Epidemiology, Hungary
  • 2 European Centre for Disease Prevention and Control (ECDC), Sweden
  • 3 Szent László Hospital, Hungary
  • 4 Semmelweis University, Hungary
Restricted access

Purchase article

USD  $25.00

1 year subscription (Individual Only)

USD  $784.00

A Hungarian soldier previously immunized against Neisseria meningitidis by quadrivalent polysaccharide vaccine was twice infected with meningococci within six weeks. The patient was treated with ceftriaxone during both episodes and he successfully recovered. His close contacts received rifampicin prophylaxis. An investigation was performed to characterize the genetic background of the pathogens to ascertain if the recurrent invasive meningococcal disease was caused by the same strain and to find out the reason for reinfection. Both meningococci belonged to the fine type Y:P1.5-2,10-1:F4-1:ST-23. This is the first description of the Europe-wide prevalent N. meningitidis serogroup Y in Hungary. In the first episode, we found wild-type rpoB allele in the non-culturable sample implying the susceptibility to rifampicin. The culturable isolate from the second episode proved resistant to rifampicin and had a point mutation in the rpoB gene. The rifampicin resistance might have evolved during the prophylactic treatment of contacts. Previous immunization of the patient with polysaccharide vaccine was ineffective due to his immunodeficiency, thus immunization with conjugate vaccine was proposed. We have proposed the implementation of centralized rifampicin susceptibility testing of N. meningitidis strains within a defined time frame to intervene and administer appropriate prophylaxis to close contacts.

  • 1.

    European Centre for Disease Prevention and Control: Surveillance of Invasive Bacterial Diseases in Europe, 2011. ECDC, Stockholm, 2013.

    • Export Citation
  • 2.

    Bröker, M., Bukovski, S., Culic, D., Jacobsson, S., Koliou, M., Kuusi, M., Simões, M. J., Skoczynska, A., Toropainen, M., Taha, M. K., Tzanakaki, G.: Meningococcal serogroup Y emergence in Europe: High importance in some European regions in 2012. Hum Vaccines Immunother 10, 17251728 (2014).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 3.

    Corless, C. E., Guiver, M., Borrow, R., Edwards-Jones, V., Fox, A. J., Kaczmarski, E. B.: Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol 39, 15531558 (2001).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 4.

    Mothershed, E. A., Sacchi, C. T., Whitney, A. M., Barnett, G. A., Ajello, G. W., Schmink, S., Mayer, L. W., Phelan, M., Taylor, T. H., Bernhardt, S. A., Rosenstein, N. E., Popovic, T.: Use of real-time PCR to resolve slide agglutination discrepancies in serogroup identification of Neisseria meningitidis. J Clin Microbiol 42, 320328 (2004).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 5.

    Johan Béla Országos Epidemiológiai Központ: A Johan Béla Országos Epidemiológiai Központ Módszertani Levele a meningococcus invazív betegségről. EPINFO S1, 2000. Available at http://semmelweis.hu/korhazhigiene/files/2012/06/Meningocossus1.pdf

    • Search Google Scholar
    • Export Citation
  • 6.

    The European Committee on Antimicrobial Susceptibility Testing: Breakpoint tables for interpretation of MICs and zone diameters. Available at http://www.eucast.org.

    • Export Citation
  • 7.

    http://neisseria.org/nm/typing/.

  • 8.

    Taha, M. K., Hedberg, S. T., Szatanik, M., Hong, E., Ruckly, C., Abad, R., Bertrand, S., Carion, F., Claus, H., Corso, A., Enríquez, R., Heuberger, S., Hryniewicz, W., Jolley, K. A., Kriz, P., Mollerach, M., Musilek, M., Neri, A., Olcén, P., Pana, M., Skoczynska, A., Sorhouet Pereira, C., Stefanelli, P., Tzanakaki, G., Unemo, M., Vázquez, J. A., Vogel, U., Wasko, I.: Multicenter study for defining the breakpoint for rifampin resistance in Neisseria meningitidis by rpoB sequencing. Antimicrob Agents Chemother 54, 36513658 (2010).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 9.

    Réti, M., Farkas, P., Csuka, D., Rázsó, K., Schlammadinger, Á., Udvardy, M. L., Madách, K., Domján, G., Bereczki, C., Reusz, G. S., Szabó, A. J., Prohászka, Z.: Complement activation in thrombotic thrombocytopenic purpura. J Thromb Haemost 10, 791798 (2012).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 10.

    European Meningococcal Epidemiology in Real Time (EMERT). Available at http://emert.eu/emert/.

  • 11.

    Kvalsvig, A. J., Unsworth, D. J.: The immunopathogenesis of meningococcal disease. J Clin Pathol 56, 417422 (2003).

  • 12.

    Fijen, C. A., Kuijper, E. J., Drogari-Apiranthitou, M., Van Leeuwen, Y., Daha, M. R., Dankert, J.: Protection against meningococcal serogroup ACYW disease in complement-deficient individuals vaccinated with the tetravalent meningococcal capsular polysaccharide vaccine. Clin Exp Immunol 114, 362369 (1998).

    • Crossref
    • Search Google Scholar
    • Export Citation
  • 13.

    Cohn, A. C., MacNeil, J. R., Clark, T. A., Ortega-Sanchez, I. R., Briere, E. Z., Meissner, H. C., Baker, C. J., Messonnier, N. E., Centers for Disease Control and Prevention (CDC): Prevention and control of meningococcal disease: Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 62, 128 (2013).

    • Search Google Scholar
    • Export Citation
  • 14.

    European Centre for Disease Prevention and Control: Public Health Management of Sporadic Cases of Invasive Meningococcal Disease and Their Contacts. ECDC, Stockholm, 2010.

    • Search Google Scholar
    • Export Citation
  • 15.

    Centers for Disease Control and Prevention: Meningococcal disease. In Hamborsky, J., Kroger, A., Wolfe, S. (eds): Epidemiology and Prevention of Vaccine-Preventable Diseases, 13th Edition. Public Health Foundation, Washington DC, 2015, pp. 231246.

    • Search Google Scholar
    • Export Citation

The author instruction is available in PDF.
Please, download the file from HERE

 

MANUSCRIPT SUBMISSION

  • Impact Factor (2018): 1.079
  • Immunology and Microbiology (miscellaneous) SJR Quartile Score (2018): Q4
  • Medicine (miscellaneous) SJR Quartile Score (2018): Q3
  • Scimago Journal Rank (2018): 0.313
  • SJR Hirsch-Index (2018): 24
  • Index Veterinarius
  • Medline
  • Referativnyi Zhurnal
  • SCOPUS
  • Science Citation Index Expanded

Language: English

Founded in 1954
Size: B5
Publication: One volume of four issues annually
Indexing and Abstracting Services:

  • Biological Abstracts
  • BIOSIS Previews
  • CAB Abstracts
  • Chemical Abstracts
  • Global Health
  • Index Medicus

 

Subscribers can access the electronic version of every printed article.

Senior editors

Editor(s)-in-Chief: Szabó, Dóra

Managing Editor(s): Kocsis, Béla

Co-editor(s): Horváth, Andrea

Editorial Board

      Ádám, É. (Budapest)
      S. Amyes (Edinburgh)
      K. Burián (Szeged) (Pécs)
      O. Dobay (Budapest)
      I. Duany (Magdeburg)
      L. Emődy (Pécs)
      A. Erdei (Budapest)
      É. M. Fenyő (Lund)
      L. Fodor (Budapest)
      J. Kónya (Debrecen)
      Y. Mándy (Szeged)
      K. Márialigeti (Budapest)
      J. Minárovits (Szeged)
      B. Nagy (Budapest)
      I. Nász (Budapest)
      K. Nékám (Budapest)
      E. Ostorházi (Budapest)
      R. Pusztai (Szeged)
      P. Rády (Houston)
      É. Rajnavölgyi (Debrecen)
      F. Rozgonyi (Budapest)
      Zs. Schaff (Budapest)
      J. G. Sinkovics (Tampa)
      J. Szekeres (Pécs)
      M. Takács (Budapest)
      E. Urbán (Szeged)

Editorial Office:
Akadémiai Kiadó Zrt.
Budafoki út 187-187, A/3, H-1117 Budapest, Hungary

Editorial Correspondence:
Acta Microbiologica et Immunologica Hungarica
Institute of Medical Microbiology
Semmelweis University
P.O. Box 370
H-1445 Budapest, Hungary
Phone: (36 1) 210 2930 ext. 56101
Fax: (36 1) 210 2959
E-mail: amih@med.semmelweis-univ.hu